[1]李 亚,宋大庆,韩翔宇,等.胰岛素强化降糖治疗对AMI伴高血糖患者心室重构及血清炎性因子影响的Meta分析[J].医学信息,2021,34(07):110-115.[doi:10.3969/j.issn.1006-1959.2021.07.030]
　LI Ya,SONG Da-qing,HAN Xiang-yu,et al.Meta-analysis of the Effect of Insulin Intensive Hypoglycemic Therapy on Ventricular Remodeling and Serum Inflammatory Factors in Patients with AMI with Hyperglycemia[J].Medical Information,2021,34(07):110-115.[doi:10.3969/j.issn.1006-1959.2021.07.030]
点击复制

胰岛素强化降糖治疗对AMI伴高血糖患者心室重构及血清炎性因子影响的Meta分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年07期
页码:
110-115
栏目:
论著
出版日期:
2021-04-01

文章信息/Info

Title:
Meta-analysis of the Effect of Insulin Intensive Hypoglycemic Therapy on Ventricular Remodeling and Serum Inflammatory Factors in Patients with AMI with Hyperglycemia
文章编号:
1006-1959（2021）07-0110-06
作者:
李 亚; 宋大庆; 韩翔宇; 等
（1.济宁医学院临床医学院，山东 济宁 272067； 2.济宁市第一人民医院急诊内科，山东 济宁 272011）
Author(s):
LI Ya; SONG Da-qing; HAN Xiang-yu; et al.
(1.Clinical School,Jining Medical University,Jining 272067,Shandong,China; 2.Department of Emergency Medicine,Jining First People’s Hospital,Jining 272011,Shandong,China)
关键词:
胰岛素; 急性心肌梗死; 心室重构; 炎性因子
Keywords:
Insulin; Acutemyocardial infarction; Ventricularremodeling; Inflammatory factors
分类号:
R977.1+5
DOI:
10.3969/j.issn.1006-1959.2021.07.030
文献标志码:
A
摘要:
目的 系统评价胰岛素强化降糖治疗对急心肌梗死（AMI）伴高血糖患者心室重构及血清炎症因子水平的影响。方法 检索2020年10月15日前发表的在AMI患者中胰岛素强化降糖治疗的随机对照研究（RCT）的文献，试验组胰岛素强化控制血糖，对照组常规降糖处理；Stata16.0软件行Meta分析，并行发表偏移及敏感性分析。结果 共纳入15篇RCT研究，共计2069例AMI伴高血糖患者；Meta分析结果显示胰岛素强化降糖治疗可显著改善AMI伴高血糖患者左室射血分数（LVEF）[WMD=5.60，95%CI（4.16，7.03），P＜0.01]，有效降低左室收缩末期容积指数（LVESVI）[WMD=-1.34，95%CI（-2.43，-0.25），P=0.016]和左室舒张末期内径（LVEDD）[WMD=-1.19，95%CI（-2.21，-0.17），P=0.022]，提高心肌灌注[WMD=2.85，95%CI（1.45，4.21），P＜0.01]，降低PCI术后无复流发生率[RR=0.53，95%CI（0.34，0.82），P=0.004]，降低炎性因子水平HS-CRP[WMD=-4.73，95%CI（-6.85，-2.61），P＜0.01]，TNF-α[WMD=-3.69，95%CI（-5.31，-2.07），P＜0.01]，降低院内总MACEs事件[RR=0.61，95%CI（0.52，0.72），P＜0.01]及长期心力衰竭发生[RR=0.26，95%CI（0.11，0.65），P=0.004]，而对长期生存率无显著影响[RR=0.94，95%CI（0.58，0.52），P=0.795]。强化降糖低血糖风险增加[RR=3.21，95%CI（1.85，5.65），P＜0.01]。结论 本研究发现胰岛素强化降糖治疗能够抑制炎症反应，改善心室重构的有益作用；但降糖过程中仍需避免发生低血糖。
Abstract:
Objective To systematically evaluate the effect of insulin intensive hypoglycemic therapy on ventricular remodeling and serum inflammatory factor levels in patients with acute myocardial infarction (AMI) with hyperglycemia.Methods To search for the literature of randomized controlled trials (RCT) of insulin intensive hypoglycemic therapy in AMI patients published before October 15, 2020,in the experimental group, insulin intensive control of blood glucose, and the control group with routine hypoglycemic treatment; Meta analysis was performed on Stata16.0 software, and the deviation and sensitivity analysis were published in parallel.Results A total of 15 RCT studies were included, with a total of 2069 patients with AMI and hyperglycemia; the results of Meta analysis showed that insulin intensive hypoglycemic therapy can significantly improve the left ventricular ejection fraction (LVEF) in patients with AMI and hyperglycemia [WMD=5.60, 95%CI(4.16, 7.03), P＜0.01,effectively reduce the left ventricular end systolic volume index (LVESVI) [WMD= -1.34, 95%CI (-2.43, -0.25), P=0.016] and left ventricular end diastolic diameter (LVEDD) [WMD=-1.19, 95% CI(-2.21, -0.17), P=0.022]：improve myocardial perfusion [WMD= 2.85, 95%CI(1.45, 4.21), P＜0.01],reduce the incidence of no-reflow after PCI [RR= 0.53, 95%CI (0.34, 0.82), P=0.004],reduce the level of inflammatory factors HS-CRP [WMD = -4.73, 95% CI(-6.85, -2.61), P<0.01], TNF-α [WMD=-3.69, 95%CI(-5.31, -2.07), P＜0.01],reduce the total number of MACEs events in the hospital [RR=0.61,95%CI(0.52, 0.72), P<0.01] and the occurrence of long-term heart failure [RR=0.26, 95%CI(0.11, 0.65),P=0.004],there was no significant effect on the long-term survival rate [RR=0.94, 95%CI(0.58, 0.52),P=0.795].The risk of intensive hypoglycemia and hypoglycemia increases [RR=3.21, 95%CI(1.85, 5.65), P<0.01].Conclusion This study found that insulin intensive hypoglycemic therapy can inhibit the inflammatory response and improve the beneficial effects of ventricular remodeling; however, it is still necessary to avoid hypoglycemia in the process of hypoglycemia.

参考文献/References:

[1]Cinar H,Avci A,Gulen M,et al.Does stress hyperglycemia affect mortality? Acute myocardial infarction - case control study[J].Arch Med Sci Atheroscler Dis,2019(4):e201-e207. [2]Cheung NW,Wong KYC,Kovoor P,et al.Stress hyperglycemia: A prospective study examining the relationship between glucose, cortisol and diabetes in myocardial infarction[J].J Diabetes Complications,2019,33(4):329-334. [3]Bouida W,Beltaief K,Msolli MA,et al.One-Year Outcome of Intensive Insulin Therapy Combinedto Glucose-Insulin-Potassium in Acute Coronary Syndrome: A Randomized Controlled Study[J].J Am Heart Assoc,2017,6(11):e006674. [4]保彦昕.非糖尿病急性心肌梗死患者血清炎症因子与血糖及胰岛素干预疗效分析[J].中西医结合心脑血管病杂志,2014,12(9):1067-1067. [5]刘伟利.胰岛素强化治疗急性心肌梗死伴高血糖50例效果观察[J].中国煤炭工业医学杂志,2009(11):14-16. [6]孟爱亮,武莉芳,孙伯玉,等.门冬胰岛素注射液强化治疗对急性心肌梗死伴应激性高血糖患者经皮冠状动脉介入术后心肌微灌注及无复流现象的影响研究[J].实用心脑肺血管病杂志,2020,28(5):1-6. [7]宋达,贺娜,孟海云.胰岛素强化治疗应激性高血糖对急性心肌梗死患者急诊PCI术后心肌微灌注的影响[J].河北医科大学学报,2018. [8]张成刚,李峰,栗先芝.辛伐他汀+胰岛素对急性心肌梗死患者血清炎症因子和脂联素的影响[J].山东医药,2009,49(5):64-65. [9]朱德军,刘展,黎伟.胰岛素强化治疗对非糖尿病急性心肌梗死患者血清炎症因子和脂联素水平的影响[J].医学临床研究,2008(8):1488-1490. [10]朱秀兰,谢凤,罗孝平.强化降糖治疗急性心肌梗塞合并Ⅱ型糖尿病患者对延长生存期的价值[J].西部医学,2016,28(3):372-374. [11]李斐,许文哲.评估强化降糖治疗对急性心肌梗塞(AMI)合并2型糖尿病(DM)患者改善心功能及预后的价值[J].中外医疗,2018,37(7):124-126. [12]杨晓燕,金惠根,承解静,等.急性心肌梗死伴应激性高血糖患者应用胰岛素的临床观察[J].上海医学,2008,31(6):385-387. [13]王少波,周善存,陈以初,等.胰岛素强化治疗急性心肌梗死伴应激性高血糖效果评价[J].山东医药, 2010(9):84-85. [14]贾志,郭牧,宋昱,等.强化血糖控制对急性心肌梗死合并应激性高血糖患者的预后影响[J].重庆医学, 2012,41(10):954-955. [15]郭盛锦,吴学周,方朝辉,等.胰岛素强化降糖治疗对急性冠脉综合征伴高血糖患者C反应蛋白和心功能影响的研究[J].中国处方药,2014(8):12-13. [16]Liu N,Sheng J,Wang Y.Effect of stress hyperglycaemia on monocyte chemoattractant protein-1 levels and the short-term prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Exp Ther Med,2019,17(5):3823-3829. [17]Yadav SK,Kambis TN,Kar S,et al.MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro[J].Cell Death Dis,2020,11(3):186. [18]Smaradottir MI,Ritsinger V,Gyberg V,et al.Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort[J].Diab Vasc Dis Res,2017,14(2):69-76. [19]Naveed MJ,Prahlad B,Saraswathi.Study of Stress Hyperglycemia as a Prognostic Factor in Acute Myocardial Infarction Patients[J].J Assoc Physicians India,2020,68(1):54.

相似文献/References:

[1]郭建华.丹参川芎嗪联合阿托伐他汀钙治疗急性心肌梗死的疗效观察[J].医学信息,2018,31(01):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
　GUO Jian-hua.Effect of Salvia Miltiorrhiza Tetramethylpyrazine Combined with Atorvastatin Calcium in the Treatment of Acute Myocardial Infarction[J].Medical Information,2018,31(07):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
[2]余湘宁,赵献明.ECMO在危重症心脏疾病中的应用研究[J].医学信息,2018,31(04):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
　YU Xiang-ning,ZHAO Xian-ming.Study on the Application of ECMO in Critical Heart Disease[J].Medical Information,2018,31(07):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
[3]何 丽.应激性高血糖与急性心肌梗死的机制研究[J].医学信息,2022,35(10):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
　HE Li.Mechanism of Stress Hyperglycemia and Acute Myocardial Infarction[J].Medical Information,2022,35(07):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
[4]毛红岩,宁国贤.冠脉介入治疗对冠心病急性心肌梗死患者 心肌损伤及心室重塑的影响[J].医学信息,2018,31(12):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
　MAO Hong-yan,NING Guo-xian.Effects of Coronary Intervention on Myocardial Injury and Ventricular Remodeling in Patients with Coronary Heart Disease and Acute Myocardial Infarction[J].Medical Information,2018,31(07):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
[5]雷 锐,李 志.冠状动脉介入及替罗非班治疗老年急性心肌梗死并 心源性休克的疗效分析[J].医学信息,2018,31(14):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
　LEI Rui,LI Zhi.Effect of Coronary Intervention and Tirofiban on Elderly Patients with Acute Myocardial Infarction and Cardiogenic Shock[J].Medical Information,2018,31(07):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
[6]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
　GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Medical Information,2019,32(07):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
[7]高 珍,刘重斌,张菊英.氧疗对急性心肌梗死患者预后的影响[J].医学信息,2018,31(18):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
　GAO Zhen,LIU Chong-bin,ZHANG Ju-ying.Effect of Oxygenic Therapy on Prognosis of Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(07):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
[8]韩 宇,朱丽丽,孙 婷,等.急性心肌梗死患者排便意愿的调查研究[J].医学信息,2018,31(20):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
　HAN Yu,ZHU Li-li,SUN Ting,et al.Investigation of Defecation Intention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(07):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
[9]陈笑玲.急救护理流程再造在急性心肌梗死急诊介入治疗中的作用观察[J].医学信息,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
　CHEN Xiao-ling.Effect of Emergency Nursing Process Reengineering on Emergency Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(07):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
[10]马洪俊,王玉平,刘 毅.主动脉内球囊反搏联合介入治疗急性心肌梗死伴心力衰竭的效果[J].医学信息,2022,35(13):136.[doi:10.3969/j.issn.1006-1959.2022.13.032]
　MA Hong-jun,WANG Yu-ping,LIU Yi.Effect of Intra-aortic Balloon Counterpulsation Combined with Interventional Therapy on Acute Myocardial Infarction Complicated with Heart Failure[J].Medical Information,2022,35(07):136.[doi:10.3969/j.issn.1006-1959.2022.13.032]

更新日期/Last Update: 1900-01-01